INTRODUCTION:
Florida continues to have one of the lowest VBAC rates in the U.S. In 2016, an obstetric hospitalist program was launched with the goals of improving safety, quality and cost. The purpose of this study was to evaluate the VBAC rate and assess adverse maternal and neonatal outcomes before and after program implementation.
METHODS:
This is a before-after retrospective cohort study at a non-academic tertiary care hospital located in Central Florida. In March 2016, AdventHealth for Women-Orlando instituted a full-time obstetric hospitalist program. For the primary outcome, pregnant women with a history of prior cesarean managed before the hospitalist program (2015) were compared to those managed after full program deployment (2017). Secondary outcomes included the cesarean delivery rate, maternal and neonatal outcomes.
RESULTS:
Between 2015 and 2017, the VBAC rate rose from 5.4% to 13.5% (OR 2.8 95% CI 1.8-4.1). Hospitalists had significantly higher rates than non-hospitalists (27.5% vs 7.3%; OR 4.8 95% CI 3.3-7.2). The cesarean delivery rate decreased from 43.7% to 38.4% (OR .80 95% CI .72-.89). For VBAC patients, uterine rupture was rare (0.8% in 2017); for failed trials of labor, the rupture rate was not significantly different (4.0% vs 4.8%; OR 1.2 95% CI .03-19.5). No unplanned hysterectomies occurred in either group. Neonatal ICU admissions for VBAC patients trended upward from 15.6% to 18.3% (OR 1.2 95% CI .42-3.5); in failed TOLACs, admissions declined (52.8% to 36.8%, OR .51 95% CI .26-1.04).
CONCLUSION:
The addition of obstetric hospitalists led to significant improvement in both VBAC and cesarean delivery rates, while maintaining patient safety goals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.